Skip to main content
. 2019 Jan 29;10(9):966–981. doi: 10.18632/oncotarget.26629

Figure 4. Kaplan–Meier analysis for PFS and OS according to the expression of circulating miRNAs in de novo metastatic patients.

Figure 4

Progression free survival and overall survival in patients with high or low miR-21 (A), miR-23b (B), miR-190 (C), miR-23b/miR-190 (D) and miR-200b (E). Curves were compared using the log rank test. P values are shown.